• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑静脉窦血栓形成和脑出血患者的神经重症监护

Neurointensive care of patients with cerebral venous sinus thrombosis and intracerebral haemorrhage.

作者信息

Wall Jacob, Enblad Per

机构信息

Department of Neuroscience/Neurosurgery, Uppsala University, Uppsala, Sweden.

Department of Neuroscience/Neurosurgery, Uppsala University, Uppsala, Sweden.

出版信息

J Clin Neurosci. 2018 Dec;58:83-88. doi: 10.1016/j.jocn.2018.10.003. Epub 2018 Oct 16.

DOI:10.1016/j.jocn.2018.10.003
PMID:30340972
Abstract

The aim was to review the neurointensive care (NIC) of cerebral venous sinus thrombosis patients with haemorrhage during a 15-year period. This is a severe condition with substantial mortality caused by increased intracranial pressure (ICP) and studies are lacking describing the complex picture of the NIC, which offers a large treatment arsenal for intracranial hypertension. Patients treated 2000-2015 were investigated. Data regarding patient characteristics, symptoms, imaging, ICP-treatment, NIC-treatment intensity, and outcome were collected and analysed. Twenty-four patients (13 women) were studied, mean age 46 (range 16-75). Twenty patients were in Glasgow coma scale motor score 6 (obeys), 2 in score 5 (localizes) and 2 in score 2 (extension) on admission. Mean haemorrhage volume was 17 ml (range 1-70). Twenty patients (83%) received unfractionated heparin and 3 (13%) low molecular weight heparin. Haemorrhagic progression occurred in 10 patients (42%). In 9 patients (38%), 4-6 of the treatment options mechanical ventilation, hyperventilation, ICP-monitoring, cerebrospinal fluid-drainage, osmotherapy, barbiturates or surgery were used. In 3 patients mechanical ventilation only was used (hyperventilation in 1). Twelve patients were not managed with any of those treatment options. At follow up, 15/24 patients (62%) had favourable outcome (4 missing). The study shows that many patients needed multiple actions to treat intracranial preassure but more than 60% achieved favourable clinical outcome. Preferably, patients with cerebral venous sinus thrombosis and haemorrhage who are awake should have fast access to NIC because it appears difficult to predict who will deteriorate and promptly need NIC treatment.

摘要

目的是回顾15年间脑静脉窦血栓形成伴出血患者的神经重症监护(NIC)情况。这是一种由颅内压(ICP)升高导致死亡率很高的严重病症,目前缺乏对NIC复杂情况的研究描述,而NIC为颅内高压提供了大量治疗手段。对2000年至2015年期间接受治疗的患者进行了调查。收集并分析了有关患者特征、症状、影像学、ICP治疗、NIC治疗强度和预后的数据。研究了24例患者(13名女性),平均年龄46岁(范围16 - 75岁)。入院时,20例患者格拉斯哥昏迷量表运动评分为6分(能听从指令),2例为5分(能定位),2例为2分(伸展反应)。平均出血量为17毫升(范围1 - 70毫升)。20例患者(83%)接受了普通肝素治疗,3例(13%)接受了低分子肝素治疗。10例患者(42%)出现出血进展。9例患者(38%)使用了4 - 6种治疗方法,包括机械通气、过度通气、ICP监测、脑脊液引流、渗透性疗法、巴比妥类药物或手术。3例患者仅使用了机械通气(其中1例还进行了过度通气)。12例患者未采用上述任何一种治疗方法。随访时,15/24例患者(62%)预后良好(4例失访)。该研究表明,许多患者需要采取多种措施来治疗颅内压,但超过60%的患者获得了良好的临床预后。对于清醒状态的脑静脉窦血栓形成伴出血患者,最好能迅速获得神经重症监护,因为似乎很难预测谁会病情恶化并急需神经重症监护治疗。

相似文献

1
Neurointensive care of patients with cerebral venous sinus thrombosis and intracerebral haemorrhage.脑静脉窦血栓形成和脑出血患者的神经重症监护
J Clin Neurosci. 2018 Dec;58:83-88. doi: 10.1016/j.jocn.2018.10.003. Epub 2018 Oct 16.
2
Outcome of heparin-treated patients with acute cerebral venous sinus thrombosis: influence of the temporal pattern of intracerebral haemorrhage.肝素治疗急性脑静脉窦血栓形成患者的预后:脑内出血时间模式的影响
Eur J Neurol. 2016 Sep;23(9):1387-92. doi: 10.1111/ene.13064. Epub 2016 Jun 14.
3
Cerebral venous thrombosis requiring invasive treatment for elevated intracranial pressure in women with combined hormonal contraceptive intake: risk factors, anatomical distribution, and clinical presentation.合并激素避孕药物使用的女性因颅内压升高而需要侵入性治疗的脑静脉血栓形成:危险因素、解剖分布和临床表现。
Neurosurg Focus. 2018 Jul;45(1):E12. doi: 10.3171/2018.4.FOCUS1891.
4
Intracerebral haemorrhage due to cerebral venous sinus thrombosis.
QJM. 2008 Mar;101(3):247-9. doi: 10.1093/qjmed/hcm138. Epub 2008 Jan 18.
5
Admission Hyperglycemia and Clinical Outcome in Cerebral Venous Thrombosis.颅内静脉血栓形成患者的入院高血糖与临床转归
Stroke. 2016 Feb;47(2):390-6. doi: 10.1161/STROKEAHA.115.011177. Epub 2015 Dec 15.
6
Systemic thrombolysis for cerebral venous and dural sinus thrombosis: a systematic review.用于脑静脉和硬脑膜窦血栓形成的全身溶栓治疗:一项系统评价
Cerebrovasc Dis. 2014;37(1):43-50. doi: 10.1159/000356840. Epub 2013 Dec 18.
7
The clinical spectrum of intracerebral hematoma, hemorrhagic infarct, non-hemorrhagic infarct, and non-lesional venous stroke in patients with cerebral sinus-venous thrombosis.脑静脉窦血栓形成患者的颅内血肿、出血性梗死、非出血性梗死和非病变性静脉性卒中的临床谱。
Eur J Neurol. 2012 Apr;19(4):537-43. doi: 10.1111/j.1468-1331.2011.03562.x. Epub 2011 Oct 28.
8
Cerebral venous sinus thrombosis: update on diagnosis and management.脑静脉窦血栓形成:诊断与治疗的最新进展。
Curr Cardiol Rep. 2014 Sep;16(9):523. doi: 10.1007/s11886-014-0523-2.
9
Treatment of sagittal sinus thrombosis associated with cerebral hemorrhage and intracranial hypertension.伴有脑出血和颅内高压的矢状窦血栓形成的治疗。
Stroke. 1988 Jul;19(7):903-9. doi: 10.1161/01.str.19.7.903.
10
Prevalence of subarachnoid haemorrhage among patients with cranial venous sinus thrombosis in the presence and absence of venous infarcts.有无静脉梗死的颅内静脉窦血栓形成患者中蛛网膜下腔出血的患病率
Neuroradiol J. 2018 Oct;31(5):496-503. doi: 10.1177/1971400918783060. Epub 2018 Jun 12.

引用本文的文献

1
Outcome of Cerebral Venous Thrombosis Requiring Mechanical Ventilation.需要机械通气的脑静脉血栓形成的结局
J Clin Med. 2025 Apr 24;14(9):2930. doi: 10.3390/jcm14092930.
2
The clinical analysis and treatment strategy of endovascular treatment for cerebral venous sinus thrombosis combined with intracerebral hemorrhage.颅内出血合并脑静脉窦血栓形成的血管内治疗的临床分析与治疗策略。
Sci Rep. 2020 Dec 18;10(1):22300. doi: 10.1038/s41598-020-78570-1.
3
Update in Neurocritical Care: a summary of the 2018 Paris international conference of the French Society of Intensive Care.
神经重症监护最新进展:法国重症监护学会2018年巴黎国际会议综述
Ann Intensive Care. 2019 Apr 16;9(1):47. doi: 10.1186/s13613-019-0523-x.